Introduction On February 11, 2020 WHO designated the name “COVID-19” for the disease
caused by “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), a novel virus …

Background: The sudden and drastic changes due to the Coronavirus Disease 19 (COVID-
19) pandemic have impacted people's physical and mental health. Clinically-vulnerable …

Aims To estimate the prevalence of established diabetes and its association with the clinical
severity and in-hospital mortality associated with COVID-19. Data synthesis We …

Background/Objective The COVID‐19 pandemic has resulted in rapid changes to end‐of‐
life care for hospitalized older adults and their families, including visitation restrictions. We …

Managing the immediate demands of the current coronavirus disease 2019 (COVID-19)
global pandemic has tested many healthcare systems across the world, to their limits. As we …

Background Delirium incidence and clinical correlates in coronavirus disease-19 (COVID-
19) pneumonia are still poorly investigated. Aim To describe the epidemiology of delirium in …

Background: The current outbreak of COVID-19 infection, which started in Wuhan, Hubei
province, China, in December 2019, is an ongoing challenge and a significant threat to …

Background: Visitor restrictions caused challenges for family members when their loved
ones had coronavirus disease (COVID-19) and were ventilated. Limited studies have …

Background COVID-19 causes significant morbidity and mortality. Despite the high
prevalence of delirium and delirium-related symptoms in COVID-19 patients, data and …

Severe acute respiratory syndrome–correlated new coronavirus (SARS-Cov-2) infection
may result in neurological signs and symptoms through different mechanisms. Although …